Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
GSK Pharma India Appoints Ronojit Biswas as New CFO in Strategic Leadership Move
GlaxoSmithKline Pharmaceuticals India names veteran finance executive Ronojit Biswas as Chief Financial Officer as part of planned leadership transition
GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Ronojit Biswas as its new Whole-Time Director and Chief Financial Officer (CFO), effective April 1, 2026, marking a strategic leadership change at the Indian arm of the global healthcare company.
The company’s board approved Biswas’s appointment for a three-year term in a move aimed at ensuring continuity and experienced financial stewardship. Biswas brings more than 25 years of international finance experience from within the GSK group, having held senior leadership roles across markets including India, Vietnam, Singapore, Brazil and the United Kingdom.
Current CFO Juby Chandy is set to step down from his roles as Whole-Time Director and CFO on March 11, 2026, to take up a new leadership position overseeing the Asia-Pacific finance function within the wider GSK group. The transition reflects what the company described as a planned succession designed to reinforce governance and performance continuity.
Industry observers say the internal elevation underlines GSK’s emphasis on experienced talent and long-term planning within its India business. Biswas, a long-serving GSK executive, began his career with the company in India and has since gained extensive operational and financial expertise in both regional and global roles.
According to company disclosures, Biswas previously served as Senior Finance Director for Global Product Strategy based in Singapore, and has held CFO responsibilities in Brazil and Vietnam, as well as leading financial reporting and performance management for GSK’s international region.
The leadership change comes at a time when Indian pharmaceutical companies are navigating evolving market dynamics, regulatory environments and global demand pressures. While GSK has not commented publicly on any immediate operational shifts, the appointment of Biswas is expected to sustain strategic financial oversight as the company pursues growth initiatives in its core therapeutic areas.